Renato Zambello

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Acute Myeloid Leukemia

Ejection Fraction

Newly Diagnosed

Multiple Myeloma

Top Venues

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Fazio, Maria Teresa Petrucci, Laura Corvatta, Alfonso Piciocchi, Roberta Della Pepa, Paola Tacchetti, Maurizio Musso, Renato Zambello, Angelo Belotti, Sara Bringhen, Elisabetta Antonioli, Concetta Conticello, Nicola Di Renzo, Valerio De Stefano, Pellegrino Musto, Barbara Gamberi, Daniele Derudas, Mario Boccadoro, Massimo Offidani, Sonia Morè
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy. EJHaem 5 (3) (2024)
Gianpietro C Semenzato, Giulia Calabretto, Antonella Teramo, Vanessa Rebecca Gasparini, Elisa Rampazzo, Gregorio Barilà, Renato Zambello
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders. Blood cancer journal 14 (1) (2024)
Gianpietro C Semenzato, Giulia Calabretto, Antonella Teramo, Vanessa Rebecca Gasparini, Elisa Rampazzo, Gregorio Barilà, Renato Zambello
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders. Blood cancer journal 14 (1) (2024)
Francesca Fazio, Maria Teresa Petrucci, Laura Corvatta, Alfonso Piciocchi, Roberta Della Pepa, Paola Tacchetti, Maurizio Musso, Renato Zambello, Angelo Belotti, Sara Bringhen, Elisabetta Antonioli, Concetta Conticello, Nicola Di Renzo, Valerio De Stefano, Pellegrino Musto, Barbara Gamberi, Daniele Derudas, Mario Boccadoro, Massimo Offidani, Sonia Morè
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy. EJHaem 5 (3) (2024)
Gianpietro C Semenzato, Giulia Calabretto, Antonella Teramo, Vanessa Rebecca Gasparini, Elisa Rampazzo, Gregorio Barilà, Renato Zambello
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders. Blood cancer journal 14 (1) (2024)
Gianpietro C Semenzato, Giulia Calabretto, Antonella Teramo, Vanessa Rebecca Gasparini, Elisa Rampazzo, Gregorio Barilà, Renato Zambello
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders. Blood cancer journal 14 (1) (2024)
Francesca Fazio, Maria Teresa Petrucci, Laura Corvatta, Alfonso Piciocchi, Roberta Della Pepa, Paola Tacchetti, Maurizio Musso, Renato Zambello, Angelo Belotti, Sara Bringhen, Elisabetta Antonioli, Concetta Conticello, Nicola Di Renzo, Valerio De Stefano, Pellegrino Musto, Barbara Gamberi, Daniele Derudas, Mario Boccadoro, Massimo Offidani, Sonia Morè
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy. EJHaem 5 (3) (2024)
Mattia D'Agostino, Giuseppe Bertuglia, Delia Rota-Scalabrini, Angelo Belotti, Sonia Morè, Paolo Corradini, Stefania Oliva, Antonio Ledda, Mariella Grasso, Vincenzo Pavone, Sonia Ronconi, Iolanda Donatella Vincelli, Stelvio Ballanti, Cristina Velluti, Claudia Cellini, Alessandro Gozzetti, Angelo D Palmas, Barbara Gamberi, Katia Mancuso, Laura Paris, Renato Zambello, Maria Teresa Petrucci, Benedetto Bruno, Pellegrino Musto, Francesca Gay
Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients. Blood (2023)
Maria Chiara Tisi, Riccardo Moia, Caterina Patti, Andrea Evangelista, Simone Ferrero, Michele Spina, Monica Tani, Barbara Botto, Melania Celli, Benedetta Puccini, Emanuele Cencini, Alice Di Rocco, Claudio Chini, Chiara Ghiggi, Renato Zambello, Manuela Zanni, Roberta Sciarra, Riccardo Bruna, Martina Ferrante, Stefano Aldo Pileri, Francesca Maria Quaglia, Caterina Stelitano, Alessandro Re, Stefano Volpetti, Vittorio Ruggero Zilioli, Annalisa Arcari, Francesco Merli, Chiara Rusconi
Long term follow-up of Rituximab plus Bendamustine and Cytarabine (R-BAC) in elderly patients with newly diagnosed MCL. Blood advances (2023)
Antonella Teramo, Andrea Binatti, Elena Ciabatti, Gianluca Schiavoni, Giulia Tarrini, Gregorio Barilà, Giulia Calabretto, Cristina Vicenzetto, Vanessa Rebecca Gasparini, Monica Facco, Iacopo Petrini, Roberto Grossi, Nadia Pisanti, Stefania Bortoluzzi, Brunangelo Falini, Enrico Tiacci, Sara Galimberti, Gianpietro Semenzato, Renato Zambello
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation. Nature communications 13 (1) (2022)
Giulia Calabretto, Enrico Attardi, Carmelo Gurnari, Gianpietro Semenzato, Maria Teresa Teresa Voso, Renato Zambello
LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don't Make an Evidence. Cancers 14 (21) (2022)
Luca Bertamini, Stefania Oliva, Delia Rota-Scalabrini, Laura Paris, Sonia Morè, Paolo Corradini, Antonio Ledda, Massimo Gentile, Giovanni De Sabbata, Giuseppe Pietrantuono, Anna Pascarella, Patrizia Tosi, Paola Curci, Milena Gilestro, Andrea Capra, Piero Galieni, Francesco Pisani, Ombretta Annibali, Federico Monaco, Anna Marina Liberati, Salvatore Palmieri, Mario Luppi, Renato Zambello, Francesca Fazio, Angelo Belotti, Paola Tacchetti, Pellegrino Musto, Mario Boccadoro, Francesca Gay
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Xavier Leleu, Eirini Katodritou, Thomas Kuehr, Evangelos Terpos, Jo Caers, Renato Zambello, Alessandra Brescianini, Tony Liang, Sally Wetten, Sorina Nicoleta Bădeliţă
Real-world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel. EJHaem 4 (1) (2022)
Evangelos Terpos, Renato Zambello, Xavier Leleu, Thomas Kuehr, Sorina N Badelita, Eirini Katodritou, Alessandra Brescianini, Tony Liang, Sally Wetten, Jo Caers
Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe. Cancers 14 (21) (2022)
Anna Fregnani, Lara Saggin, Ketty Gianesin, Laura Quotti Tubi, Marco Carraro, Gregorio Barilà, Greta Scapinello, Giorgia Bonetto, Maria Pesavento, Tamara Berno, Antonio Branca, Carmela Gurrieri, Renato Zambello, Gianpietro Semenzato, Livio Trentin, Sabrina Manni, Francesco A Piazza
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma. Cancers 14 (17) (2022)
Jani Huuhtanen, Dipabarna Bhattacharya, Tapio Lönnberg, Matti Kankainen, Cassandra Kerr, Jason Theodoropoulos, Hanna L M Rajala, Carmelo Gurnari, Tiina Kasanen, Till Braun, Antonella Teramo, Renato Zambello, Marco Herling, Fumihiro Kawakami, Toru Kawakami, Marko Salmi, Thomas Loughran, Jaroslaw P Maciejewski, Harri Lähdesmäki, Tiina Kelkka, Mohamed El Missiry
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8 + T-cell large granular lymphocytic leukemia. Nature communications 13 (1) (2022)
Gianpietro C Semenzato, Antonella Teramo, Giulia Calabretto, Vanessa Rebecca Gasparini, Renato Zambello
All that glitters is not LGL Leukemia. Leukemia 36 (11) (2022)
Xavier Leleu, Eirini Katodritou, Thomas Kuehr, Evangelos Terpos, Jo Caers, Renato Zambello, Alessandra Brescianini, Tony Liang, Sally Wetten, Sorina Nicoleta Bădeliţă
Real-world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel. EJHaem 4 (1) (2022)
Gianpietro C Semenzato, Renato Zambello
Interrogating molecular genetics to refine LGLL classification. Blood 139 (20) (2022)
Dipabarna Bhattacharya, Antonella Teramo, Vanessa Rebecca Gasparini, Jani Huuhtanen, Daehong Kim, Jason Theodoropoulos, Gianluca Schiavoni, Gregorio Barilà, Cristina Vicenzetto, Giulia Calabretto, Monica Facco, Toru Kawakami, Hideyuki Nakazawa, Brunangelo Falini, Enrico Tiacci, Fumihiro Ishida, Gianpietro C Semenzato, Tiina Kelkka, Renato Zambello, Mohamed El Missiry
Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia. Blood cancer journal 12 (2) (2022)
Giulia Calabretto, Enrico Attardi, Antonella Teramo, Valentina Trimarco, Samuela Carraro, Sandra Mossuto, Gregorio Barilà, Cristina Vicenzetto, Vanessa Rebecca Gasparini, Monica Crugnola, Pasquale Niscola, Antonella Poloni, Valentina Giai, Valentina Gaidano, Carlo Finelli, Roberta Bertorelle, Cinzia Candiotto, Marco Pizzi, Gianni Binotto, Monica Facco, Fabrizio Vianello, Livio Trentin, Gianpietro C Semenzato, Renato Zambello, Valeria Santini
Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience. Leukemia 36 (7) (2022)
Roberto Mina, Antonietta Pia Falcone, Sara Bringhen, Anna Marina Liberati, Norbert Pescosta, Maria Teresa Petrucci, Giovannino Ciccone, Andrea Capra, Francesca Patriarca, Delia Rota-Scalabrini, Francesca Bonello, Caterina Musolino, Michele Cea, Renato Zambello, Paola Tacchetti, Angelo Belotti, Claudia Cellini, Laura Paris, Mariella Grasso, Sara Aquino, Lorenzo De Paoli, Giovanni De Sabbata, Stelvio Ballanti, Massimo Offidani, Mario Boccadoro, Federico Monaco, Paolo Corradini, Alessandra Larocca
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial. Blood cancer journal 11 (12) (2021)
Mattia D'Agostino, Alessandra Larocca, Massimo Offidani, Anna Marina Liberati, Gianluca Gaidano, Maria Teresa Petrucci, Daniele Derudas, Andrea Capra, Renato Zambello, Nicola Cascavilla, Paolo de Fabritiis, Vanessa Innao, Francesca Bonello, Francesca Patriarca, Giulia Benevolo, Nicola Giuliani, Gabriele Aitoro, Tommasina Guglielmelli, Francesco Di Raimondo, Paolo Corradini, Pellegrino Musto, Roman Hájek, Pieter Sonneveld, Mario Boccadoro, Sara Bringhen
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score. Blood cancer journal 11 (4) (2021)